Epigenetic Modifications Associated with Exposure to Endocrine Disrupting Chemicals in Patients with Gestational Diabetes Mellitus

Int J Mol Sci. 2021 Apr 29;22(9):4693. doi: 10.3390/ijms22094693.

Abstract

Gestational diabetes mellitus (GDM) remains a significant clinical and public health issue due to its increasing prevalence and the possibility for numerous short- and long-term complications. The growing incidence of GDM seems to coincide with the widespread use of endocrine disrupting chemicals (EDCs). The extensive production and common use of these substances in everyday life has resulted in constant exposure to harmful substances from the environment. That may result in epigenetic changes, which may manifest themselves also after many years and be passed on to future generations. It is important to consider the possible link between environmental exposure to endocrine disrupting chemicals (EDCs) during pregnancy, epigenetic mechanisms and an increased risk for developing gestational diabetes mellitus (GDM). This manuscript attempts to summarize data on epigenetic changes in pregnant women suffering from gestational diabetes in association with EDCs. There is a chance that epigenetic marks may serve as a tool for diagnostic, prognostic, and therapeutic measures.

Keywords: EDCs; epigenetics; gestational diabetes mellitus.

Publication types

  • Review

MeSH terms

  • DNA Methylation / drug effects
  • Diabetes, Gestational / etiology
  • Diabetes, Gestational / genetics*
  • Diabetes, Gestational / physiopathology
  • Endocrine Disruptors / adverse effects*
  • Endocrine Disruptors / pharmacokinetics
  • Environmental Exposure / adverse effects
  • Epigenesis, Genetic / drug effects*
  • Female
  • Gene Expression Regulation / drug effects
  • Humans
  • Infant, Newborn
  • Pregnancy

Substances

  • Endocrine Disruptors